Millipore Sigma Vibrant Logo

203890 CRAC Channel Inhibitor, BTP2 - CAS 223499-30-7 - Calbiochem

View Products on Sigmaaldrich.com
203890
가격 및 재고 조회

개요

Replacement Information

주요 사양표

CAS #Empirical Formula
223499-30-7C₁₅H₉F₆N₅OS

가격 및 재고여부

카탈로그 번호 재고 정보패킹 포장 단위 가격(VAT 별도) 수량
203890-5MGCN
재고 정보 검색...
현재 재고 없음
현재 재고 없음
예상 출고 가능일 
단종품
제한된 수량 가능
재고여부 확인
    Remaining: will advise
      Remaining: will advise
      추천사항
      고객 서비스로 문의
      Contact Customer Service

      Plastic ampoule 5 mg
      가격 검색...
      가격을 검색할 수 없습니다
      Minimum Quantity needs to be mulitiple of
      Maximum Quantity is
      가격 문의 추가 정보
      ()이 할인됨
       
      가격 문의
      Description
      OverviewA cell-permeable pyrazole that acts as a more potent blocker of Stim1 and Orai1-coupled CRAC (Ca2+ release-activated Ca2+) channel-mediated SOCE (store-operated Ca2+ entry) in RBL-2H3 cells (IC50 = 590 nM by Fura-2; peak current density pA/pF = -1.13 and -7.50, respectively, with or without 3 µM BTP2/Pyr2 by whole cell clamp) than the transient receptor potential cation channel TRPC3-mediated ROCE (receptor-operated Ca2+ entry) inTRPC3-expressing HEK293 cells (IC50 = 4.21 µM by Fura-2; pA/pF = -1.54 and -18.50, respectively, with or without 3 µM BTP2/Pyr2). A great complement to Pyr 3 (Cat. No. 648490), Pyr6, and Pyr10 in Ca2+ signaling studies.
      Catalogue Number203890
      Brand Family Calbiochem®
      Synonyms[N-{4-[3,5-bis(Trifluoromethyl)-1H-pyrazol-1-yl]phenyl}-4-methyl-1,2,3-thiadiazole-5-carboxamide], Pyr2, TPRC3 Channel Inhibitor II
      References
      ReferencesSchleifier, H., et al. 2012. Br J Pharmacol In Press
      Yonetoku, Y., et al. 2006. Bioorg. Med. Chem. 14, 5370.
      Yonetoku, Y., et al. 2006. Bioorg. Med. Chem. 14, 4750.
      Zitt, C., et al. 2004. J. Biol. Chem. 279, 12927.
      Trevillyan, J.M., et al. 2001. J. Biol. Chem. 276, 48118.
      Djuric, S.W., et al. 2000. J. Med. Chem. 43, 2975.
      Product Information
      CAS number223499-30-7
      ATP CompetitiveN
      FormSolid
      Hill FormulaC₁₅H₉F₆N₅OS
      Chemical formulaC₁₅H₉F₆N₅OS
      ReversibleN
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      ApplicationCRAC Channel Inhibitor, BTP2, CAS 223499-30-7, is a cell-permeable, potent blocker of Stim1 and Orai1-coupled Ca2+ release-activated Ca2+ channel-mediated SOCE in RBL-2H3 cells (IC50 = 590 nM).
      Biological Information
      Primary TargetCRAC Channel
      Primary Target IC<sub>50</sub>590 nM by Fura-2
      Purity≥95% by HPLC
      Physicochemical Information
      Cell permeableY
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Standard Handling
      Storage +2°C to +8°C
      Protect from Light Protect from light
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 6 months at -20°C.
      Packaging Information
      Packaged under inert gas Packaged under inert gas
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      카탈로그 번호 GTIN
      203890-5MGCN 04055977204070

      Documentation

      CRAC Channel Inhibitor, BTP2 - CAS 223499-30-7 - Calbiochem MSDS

      타이틀

      물질안전보건자료(MSDS) 

      CRAC Channel Inhibitor, BTP2 - CAS 223499-30-7 - Calbiochem Certificates of Analysis

      TitleLot Number
      203890

      References

      참고문헌 보기
      Schleifier, H., et al. 2012. Br J Pharmacol In Press
      Yonetoku, Y., et al. 2006. Bioorg. Med. Chem. 14, 5370.
      Yonetoku, Y., et al. 2006. Bioorg. Med. Chem. 14, 4750.
      Zitt, C., et al. 2004. J. Biol. Chem. 279, 12927.
      Trevillyan, J.M., et al. 2001. J. Biol. Chem. 276, 48118.
      Djuric, S.W., et al. 2000. J. Med. Chem. 43, 2975.
      Data Sheet

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision21-June-2013 JSW
      Synonyms[N-{4-[3,5-bis(Trifluoromethyl)-1H-pyrazol-1-yl]phenyl}-4-methyl-1,2,3-thiadiazole-5-carboxamide], Pyr2, TPRC3 Channel Inhibitor II
      DescriptionA cell-permeable pyrazole that acts as a more potent blocker of Stim1 and Orai1-coupled CRAC (Ca2+ release-activated Ca2+) channel-mediated SOCE (store-operated Ca2+ entry) in RBL-2H3 cells (IC50 = 590 nM by Fura-2; peak current density pA/pF = -1.13 and -7.50, respectively, with or without 3 µM BTP2/Pyr2 by whole cell clamp) than the transient receptor potential cation channel TRPC3-mediated ROCE (receptor-operated Ca2+ entry) inTRPC3-expressing HEK293 cells (IC50 = 4.21 µM by Fura-2; pA/pF = -1.54 and -18.50, respectively, with or without 3 µM BTP2/Pyr2). A great complement to Pyr 3 (Cat. No. 648490), Pyr6, and Pyr10 in Ca2+ signaling studies.
      FormSolid
      Intert gas (Yes/No) Packaged under inert gas
      CAS number223499-30-7
      Chemical formulaC₁₅H₉F₆N₅OS
      Structure formulaStructure formula
      Purity≥95% by HPLC
      SolubilityDMSO (5 mg/ml)
      Storage Protect from light
      +2°C to +8°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 6 months at -20°C.
      Toxicity Standard Handling
      ReferencesSchleifier, H., et al. 2012. Br J Pharmacol In Press
      Yonetoku, Y., et al. 2006. Bioorg. Med. Chem. 14, 5370.
      Yonetoku, Y., et al. 2006. Bioorg. Med. Chem. 14, 4750.
      Zitt, C., et al. 2004. J. Biol. Chem. 279, 12927.
      Trevillyan, J.M., et al. 2001. J. Biol. Chem. 276, 48118.
      Djuric, S.W., et al. 2000. J. Med. Chem. 43, 2975.